PRESENTATION

Q1 2022 — Presentation

Q1 2022PDF · 32 pages4.6 MB
0
Presentation to Investors and Analysts
HSBC Holdings plc 1Q22 Results

-- 1 of 32 --

1Q22 results 	Appendix
Our purpose, values and ambition support the execution of our strategy
Opening up a world of opportunity	Our purpose
Our values
Our strategy
Our ambition To be the preferred international financial partner for our clients
We value difference 	We succeed together 	We take responsibility 	We get it done
Focus on strengths 	Digitise at scale 	Energise for growth 	Transition to net zero

-- 2 of 32 --

2
1Q22 results 	Appendix
1Q22 highlights
3 Good cost control, with adjusted costs down 2% vs. 1Q21; firmly on track to meet our FY22
target of stable adjusted costs
5 CET1 ratio1 of 14.1%, down 1.7ppts vs. 4Q21, of which c.0.8ppts related to expected regulatory
impacts and c.0.4ppts related to adverse fair value movements through OCI
2 More normalised ECL, with a charge of $0.6bn (25bps of average loans). Stage 3 charges
remain low
1 1Q22 reported revenue of $12.5bn, down $0.5bn (4%) vs. 1Q21; reported PBT of $4.2bn
down $1.6bn (28%) vs. 1Q21, with the positive impact from higher rates more than offset by
lower non-NII and higher ECL
4 Strong adjusted lending growth of $21bn (2%) vs. 4Q21, particularly CMB and GBM in Trade,
supported by strong mortgage growth in WPB
A reconciliation of reported results to adjusted results can be found on slide 15, the remainder of the presentation unless otherwise stated, is presented on an adjusted basis
Figures throughout this presentation may be subject to rounding adjustments and therefore may not sum precisely to totals given in charts, tables or commentary
6 	Strategy execution is on track

-- 3 of 32 --

3
1Q22 results 	Appendix
Business highlights
Global business highlights 	Geographic highlights 	Sustainability
Operations and Technology
* Includes renewal and refinancing activity. Note, clients may elect not to draw down on approved limits; from 3Q21 we have chosen to exclude past approvals from the same client within 60 calendar days from approved limit analysis, comparative data have
been re-presented accordingly
 	Strong Insurance performance excluding adverse
market impacts; VNB up 25% vs. 1Q21
 	Mortgage growth of $6bn vs. 4Q21, particularly in
the UK ($3bn)
 	Strong CMB lending growth, up $9bn (3%) vs.
4Q21, with C&L up $6bn and trade balances up $3bn
 	CMB fees up 13% vs. 1Q21 across all regions and
particularly in GLCM and Trade
 	1Q22 CMB value of approved limits* of $58bn,
c.$7bn higher vs. FY21 quarterly average of $51bn
 	Trade balances up $15bn (22%) vs. 1Q21 to $86bn
 	GLCM balances across CMB and GBM up $51bn
(7%) vs. 1Q21 to $749bn
 	#1 in the EMEA IPO league tables with an 11%
market share2
Per our announcement on 16 March 223, we
have committed to:
1) 	Publish a bank-wide Climate
Transition Plan in 2023
2) 	A science-aligned phase-down of
fossil fuel financing
3) 	Undertake a review of and update our
wider financing and investment
policies critical to achieving net zero by
2050
Signed quantum computing partnership
with IBM
Adjusted PBT by region, $bn
1Q21 	1Q22
Europe 	1.5 	0.7
o/w: UK RFB	
1.1	
1.3
o/w: HSBC Bank plc	
0.8	
0.2
Asia 	3.8 	2.9
o/w: Hong Kong	
1.9	
1.1
o/w: Asia ex-HK	
1.9	
1.8
MENA 	0.3 	0.4
North America 	0.5 	0.5
Latin America 	0.2 	0.2
Real estate footprint down 25% since
FY19, or c.4.7 million sq. feet, with a further
7 buildings closed in 1Q22
 	Profitable in all regions
 	HSBC UK PBT up $0.2bn (14%) vs.
1Q21, good revenue growth supported
by further ECL releases
 	MENA PBT up $0.1bn (21%) vs. 1Q21
driven by strong FX performance
Top 3 globally for GSS bond issuance
with a market share of 6.2% 4

-- 4 of 32 --

4
1Q22 results 	Appendix
Hong Kong and mainland China
Hong Kong adjusted performance
$m 	1Q21 	4Q21 	1Q22
NII 	1,815 	1,838 	1,896
Non-NII 	2,163 	1,255 	1,342
Revenue 	3,978 	3,093 	3,238
ECL 	(84) 	(479) 	(205)
Costs 	(1,992) 	(1,992) 	(1,962)
PBT* 	1,908 	626 	1,072
Memo: WPB insurance
market impacts
(69)	
91 	(297)
Mainland China adjusted performance
$m 	1Q21 	4Q21 	1Q22
NII 	410 	433 	433
Non-NII 	481 	540 	541
Revenue 	891 	973 	974
ECL 	17 	(48) 	(73)
Costs 	(636) 	(751) 	(703)
Associates 	716 	578 	672
PBT 	988 	752 	870
 	1Q22 revenue up 9% vs. 1Q21; NII up 6%
and non-NII up 12%
 	Costs up due to increased investments in
technology
 	Lending up $6bn (11%) vs. 1Q21 to
$56bn, of which CMB was $4bn (up 17%)
 	Increased stake in HSBC Qianhai Securities
joint venture from 51% to 90%
 	Pinnacle Venture on track: c.700 Wealth
Planners hired to date; total planned hires of
c.3,000 in the next few years
Hong Kong digital highlights
96% of WPB transactions completed
digitally5 in FY21
HSBC Hong Kong became the first
bank with approval to offer remote,
branch-like sales and service
activities (‘Home Banking’)
 	In 1Q22 Hong Kong was impacted by branch
closures from government restrictions and muted
market sentiment
 	1Q21 non-NII strong due to elevated levels of
market activity, with good performance in Wealth
distribution and Global Markets
 	1Q22 non-NII impacted by:
 	Adverse insurance market impact movements
of $228m
 	Lower client activity drove lower equities
brokerage income and markets-linked revenue
 	Despite a more subdued performance in parts of
the business, Insurance sales were good: VNB
up 20% vs. 1Q21 with a strong remote
proposition
 	As of 19 April 22, all branches in Hong Kong have
fully reopened
 	Interest rate rises are expected to support future
NII growth
 	Client activity expected to return to normal
levels over time
5 minute digital onboarding
journeys now available
* 1Q22 PBT includes associate income of $1m (1Q21: $6m; 4Q21:$4m)

-- 5 of 32 --

5
1Q22 results 	Appendix
$m 	1Q22 	1Q21 	Δ
NII 	6,999 	6,338 	10 %
Non-NII 	5,550 	6,624 	(16)%
Revenue 	12,549 	12,962 	(3)%
ECL 	(642) 	420 	>(100)%
Costs 	(7,857) 	(7,998) 	2 %
Associates 	656 	896 	(27)%
Adjusted PBT 	4,706 	6,280 	(25)%
Significant items and FX translation 	(540) 	(501) 	(8)%
Reported PBT 	4,166 	5,779 	(28)%
Profit attributable to ordinary shareholders 	2,803 	3,880 	(28)%
Reported EPS, $ 	0.14 	0.19 	$(0.05)
Impact of sig items on reported EPS, $ 	(0.02) 	(0.03) 	$0.01
Reported RoTE6 (annualised), % 	6.8 	10.2 	(3.4)ppts
$bn 	1Q22 	4Q21 	Δ
Customer loans 	1,055 	1,034 	2%
Customer deposits 	1,710 	1,689 	1%
Reported RWAs 	862 	838 	(3)%
CET1 ratio1 , % 	14.1 	15.8 	(1.7)ppts
TNAV per share, $ 	7.80 	7.88 	$0.08
1Q22 results summary
 	1Q22 reported PBT of $4.2bn; adjusted PBT of $4.7bn
 	NII of $7.0bn, up vs. 1Q21 reflecting interest rate rises and
lending growth
 	Non-NII of $5.6bn, down vs. 1Q21, negatively impacted by
$342m of adverse insurance market impact movements in WPB
and slowdown in Asia Wealth following Covid-related
restrictions
 	ECL charge of $0.6bn, including the impact of deterioration in
the forward economic guidance and charges relating to Russian
counterparties
 	Costs of $7.9bn, down vs. 1Q21 as increased investment in
technology partly offset cost saves and lower performance
related pay
 	Associate income of $0.7bn, a more normal performance due
to the non-repeat of 1Q21 revaluation gains in BGF
 	Customer lending up $21bn vs. 4Q21, with strong growth
across the global businesses
 	TNAV per share down $0.08 vs. 4Q21; profits were more than
offset by negative fair value movements through OCI and FX

-- 6 of 32 --

6
1Q22 results 	Appendix
(8)%
Adjusted revenue performance
284	(335)
Corporate
Centre
1Q21 	WPB 	CMB
12,549
(164)
GBM
(198)
1Q22
12,962
Revenue by global business*, $m
 	WPB down 6% vs. 1Q21. Personal banking up $216m (7%) from higher
interest rates and balance sheet growth, offset by adverse insurance market
impacts of $342m and lower Investment Distribution (down $218m, 21%)
 	CMB up 9% vs. 1Q21 with strong performance across CMB products
reflecting balance sheet and fee growth, particularly GLCM (up $177m, 21%)
 	GBM down 4% vs. 1Q21, with strong client volumes and volatility
benefitting Markets, with Global FX up $142m (15%). Banking up $62m
(4%) primarily from higher rates and volumes in GLCM (up $89m, 21%).
Principal Investments down $112m due to lower revaluation gains
Includes $(342)m of
insurance market
impacts
Net fee income by global business, $m
 	Group net fee income down 8% vs. 1Q21
 	WPB fees down 15% vs. 1Q21 due to lower equity brokerage activity
 	CMB fee income up 13% vs. 1Q21, growth across all CMB products
 	GBM fees down 15% vs. 1Q21, lower client activity in MSS was
partly offset by good growth in GLCM
1,601 1,349 	1,365
868 922 	979
924
818 	788
3,084
4Q21
(5)	(2)
1Q21 	1Q22
(6)
3,391
3,126
1%
GBM
WPB
CMB
Corporate Centre
* Using March 2022 average FX rates, FY21 adjusted revenue would decrease by c.$1.4bn, and FY21 adjusted costs would decrease by c.$0.9bn, primarily due to the weakening of GBP against USD

-- 7 of 32 --

7
1Q22 results 	Appendix
2,179 	2,199 	2,208 	2,251 	2,259
121bps 	120bps 	119bps
126bps
119bps
7bps
Net interest income and margin
Reported NIM trend
 	1Q22 reported NII of $7.0bn was up $0.5bn
(7%) vs. 1Q21 due to the impact of rising global
interest rates. Reported AIEAs increased $80bn
(4%)
 	1Q22 NIM of 1.26%, up 7bps vs. 4Q21,
increased asset yields and volumes were partly
offset by higher liability costs
 	1Q22 reported NII was up $0.2bn (3%) vs.
4Q21, more than offsetting a lower day count
 	Continued improvement in interest rate
outlook, leading to higher NII expectations going
forward
Discrete quarterly
reported NIM
Average interest
earning assets
(AIEAs), $bn
of which:
significant items
Reported NII, $m
3Q21
(7)
1Q22	4Q21
18
1Q21 	2Q21
(2)
6,584	6,514 	6,610 	6,781 6,997
Reported NIM progression, bps
12
4Q21 	Asset yields
(6)
Liability costs
1
Funding mix 	1Q22
119 126

-- 8 of 32 --

8
1Q22 results 	Appendix
0.17 	0.10 	0.24 	(0.17)
Credit performance
Adjusted ECL release/(charge) trend
 	1Q22 ECL net charge of $642m included:
 	Net charges relating to Russian
counterparties of c.$250m (Stage 2) and
c.$160m relating to China CRE (Stage
2&3)
 	Low overall Stage 3 charges of
c.$400m
 	Our Stage 1-2 coverage remained stable; a
c.$600m release of Covid-19-related
allowances was partly offset by:
 	$275m charge for broader Russia-
Ukraine war risks and higher inflation
risks
 	$250m management overlay for
economic uncertainty
 	Stage 3 loans at 1.8% of total loans; stable
vs. 4Q21
 	Continue to expect ECL charge to normalise
towards 30bps in FY227
ECL release /
(charge) as a %
of average
gross loans and
advances
ECL release/(charge) by stage, $bn	ECL release/(charge) by geography, $m
420 270
639
(451) (642)
1Q21 	1Q22	2Q21 	4Q21	3Q21
ECL, $m
1Q22 	Stage 1-2 	Stage 3 	Total
Wholesale 	(0.0) 	(0.3) 	(0.3)
Personal 	(0.3) 	(0.1) 	(0.3)
Total 	(0.3) 	(0.4) 	(0.6)
1Q22 	4Q21
Hong Kong* 	(205) 	(479)
Mainland China 	(73) 	(48)
Other Asia 	(33) 	—
UK RFB 	84 	225
HSBC Bank plc 	(262) 	47
Mexico 	(101) 	(145)
Other 	(52) 	(51)
Total 	(642) 	(451)
* 1Q22 and 4Q21 charge largely relates to offshore China CRE exposures booked on Hong Kong balance sheets
(0.25)

-- 9 of 32 --

9
1Q22 results 	Appendix
Adjusted costs
208
422
1Q21
7,998
(580)
Cost
saves
41
Marketing,
T&E
1Q22
(232)
PRP 	Tech
spend 9
Other items*
7,857
(2)%
PRP
8,180
Cost
saves
4Q21
(176) (55)
Marketing,
T&E
13 	128
Tech
spend9
(233)
Other items*
7,857
1Q22
(4)%
Operating expenses trend, $m
1,543 	1,438 1,424 1,540 1,649
6,455
8,296
1Q22
7,857
4Q21	1Q21
6,356
2Q21 	3Q21
7,445 	116
6,640 	6,208
7,998 	7,794
Other Group costs 	UK bank levy	Technology 8
1Q22 vs. 1Q21, $m	1Q22 vs. 4Q21 (excl. levy), $m
 	1Q22 costs of $7.9bn, down $0.1bn (2%) vs. 1Q21, as cost saves and
lower performance-related pay (PRP) was offset by higher technology spend,
investment, volume growth and inflation
 	1Q22 cost saves of $0.6bn had associated CTA of $0.4bn; programme
cost saves to date of $3.9bn and associated CTA spend of $4.1bn
 	Continue to expect FY22 adjusted costs in line with FY21
* Other items includes: inflation, volume growth and investments
6,021

-- 10 of 32 --

10
1Q22 results 	Appendix
Capital adequacy
1Q21 	4Q21 	1Q22
Common equity tier 1 capital, $bn 	134.5 	132.6 	121.4
Reported risk-weighted assets, $bn 	846.8 	838.3 	862.3
CET1 ratio1 , % 	15.9 	15.8 	14.1
Leverage ratio exposure, $bn 	2,930.2 	2,962.7 	2,532.9
Leverage ratio1 , % 	5.4 	5.2 	5.7
Capital progression
 	CET1 ratio of 14.1%, down 1.7ppts vs. 4Q21. CET1
capital decreased by $11.2bn, mainly due to:
 Negative after-tax OCI movements: $3.1bn
 Software capitalisation benefit reversal: $2.9bn
 Higher threshold deductions: $2.2bn, primarily due to
lower absolute levels of CET1 capital and acquisitions
 	Reported RWAs of $862bn, up $24bn (3%) vs. 4Q21,
including a decrease of $9bn from FX moves:
 $27bn increase from regulatory changes
 RWA increases from loan growth mitigated by
improved asset quality and model updates
 	CET1 ratio for the remainder of FY22 will be impacted by:
 France loss on disposal in 3Q22: c.35bps
 Acquisitions closing in 2H22: c.7bps
 	We aim to be within our c.14—14.5% target range at
FY22, but CET1 could dip below that in the interim
e.g. on the realisation of the French retail loss on sale
 	$1bn buyback announced in February 2022 expected to
start in May; further buybacks unlikely in 2022 due
to lower CET1 ratio. Buybacks remain within our capital
management toolkit
CET1 ratio, %
Profits (net
of dividend
accrual) 10
14.1
Regulatory
changes*
(0.1)
FX
translation
differences
Movements
through
OCI
(0.5)
Other
movements
1Q22
0.1 	(0.4)
(0.8)
4Q21
15.0 (0.0)
Buyback
15.8
132.6
838.3
121.4	CET1, $bn
RWAs, $bn 	862.3	27.1 	(8.5)
(3.1) 	(3.7)	(1.0) 	1.1
Net of $1.5bn
regulatory
dividend
deduction
(3.2)
5.4
Includes $2.2bn
of increased
threshold
deductions
(1.3)
* Regulatory changes include impacts from software capitalisation benefit reversal, IRB repair and the UK’s implementation of the CRR II rules; includes $0.2bn of related threshold deductions not included in other movements

-- 11 of 32 --

11
1Q22 results 	Appendix
Conclusion
3 	Broader loan growth beginning to come through
2 	Costs well under control; firmly on track to meet our FY22 cost target
1 Good set of results, with negative insurance market impacts and weakness in Investment
Distribution balanced by strong Personal Banking, CMB and GBM performance
4 More confident of achieving our RoTE ambition of >10% for FY23 11; strategy execution
remains on track

-- 12 of 32 --

12
Que everisque iminvendis et accusdam ipsa
volesto tatemod ioribus et eum qui resti aute
volupta cum apit quatisquunt quate volorepel is
incium assi ilibere ssitat.
Section title	Appendix

-- 13 of 32 --

13
1Q22 results 	Appendix
Russia exposures
 Our exposures booked in Russia were $1.3bn at 1Q22, including $0.9bn
of local currency deposits with banks
 Wholesale exposures booked outside of Russia were $0.4bn, primarily
Russian banks and corporates in HSBC Bank (NRFB)
Assets 	$m
Third
party assets
Loans and advances to banks* 	898
Loans and advances to customers 	72
Reverse repo 	135
Cash and balances at central bank 	4
Other third party assets 	74
Intercompany assets 	348
Total assets 	1,531
Russian entity balance sheet detail and Russia exposures
Liabilities and equity 	$m
Third
party liabilities
Customer accounts 	1,180
Other third party liabilities 	59
Intercompany liabilities 	141
Total liabilities 	1,380
Equity 	151
Total liabilities and equity 	1,531
* Loans and advances to banks includes $0.8bn of cash balances held at the Central Bank of the Russian Federation
Wholesale exposures booked outside of Russia, $bn 	0.4
Off-balance sheet unfunded commitments, $bn 	0.2
At 31 March 2022

-- 14 of 32 --

14
1Q22 results 	Appendix
Key financial metrics
Reported results, $m 	1Q22 	4Q21 	1Q21
NII 	6,997 	6,781 	6,514
Other Income 	5,467 	5,208 	6,472
Revenue 	12,464 	11,989 	12,986
ECL 	(642) 	(450) 	435
Costs 	(8,312) 	(9,544) 	(8,527)
Associate income 	656 	669 	885
Profit before tax 	4,166 	2,664 	5,779
Tax 	(723) 	(635) 	(1,211)
Profit after tax 	3,443 	2,029 	4,568
Profit attributable to ordinary shareholders (‘PAOS’) 	2,803 	1,788 	3,880
Basic earnings per share, $ 	0.14 	0.09 	0.19
Diluted earnings per share, $ 	0.14 	0.09 	0.19
Dividend per share (in respect of the period), $ 	— 	0.18 	—
Net interest margin (annualised), % 	1.26 	1.19 	1.21
Alternative performance measures, $m 	1Q22 	4Q21 	1Q21
Adjusted NII 	6,999 	6,745 	6,338
Adjusted other income 	5,550 	5,275 	6,624
Adjusted revenue 	12,549 	12,020 	12,962
Adjusted ECL 	(642) 	(451) 	420
Adjusted costs 	(7,857) 	(8,296) 	(7,998)
Adjusted associate income 	656 	672 	896
Adjusted profit before tax 	4,706 	3,945 	6,280
PAOS excl. goodwill and other intangible impairment and PVIF 	2,624 	2,373 	3,940
Return on average tangible equity (annualised), % 	6.8 	6.0 	10.2
Return on average equity (annualised), % 	6.5 	4.0 	9.0
Adjusted net loans and advances to customers 	1,055,307 	1,033,901 	1,016,695
Adjusted customer accounts 	1,709,685 	1,688,509 	1,611,220
Adjusted cost efficiency ratio, % 	62.6 	69.0 	61.7
ECL charge/(release) as a % of average gross loans and
advances to customers (annualised) 0.25 	0.17 	(0.17)
Reported balance sheet, $m 	1Q22 	4Q21 	1Q21
Total assets 	3,021,512 	2,957,939 	2,958,629
Net loans and advances to customers 	1,055,307 	1,045,814 	1,040,207
Customer accounts 	1,709,685 	1,710,574 	1,650,019
Quarterly average interest-earning assets 	2,259,198 	2,251,433 	2,178,918
Reported loans and advances to customers as % of
customer accounts 61.7 	61.1 	63.0
Total shareholders’ equity 	196,293 	198,250 	199,210
Tangible ordinary shareholders’ equity 	155,833 	158,193 	157,357
Net asset value per ordinary share at period end, $ 	8.71 	8.76 	8.64
Tangible net asset value per ordinary share at
period end, $ 7.80 	7.88 	7.78
Capital, leverage and liquidity 	1Q22 	4Q21 	1Q21
Reported risk-weighted assets, $bn 	862.3 	838.3 	846.8
CET1 ratio, % 	14.1 	15.8 	15.9
Total capital ratio (transitional), % 	19.2 	21.2 	21.6
Leverage ratio, % 	5.7 	5.2 	5.4
High-quality liquid assets (liquidity value), $bn 	695 	717 	695
Liquidity coverage ratio, % 	134 	138 	143
Share count, m 	1Q22 	4Q21 	1Q21
Basic number of ordinary shares outstanding 	19,968 	20,073 	20,226
Basic number of ordinary shares outstanding and dilutive
potential ordinary shares 20,134 	20,189 	20,335
Quarterly average basic number of ordinary shares outstanding 	20,024 	20,152 	20,191

-- 15 of 32 --

15
1Q22 results 	Appendix
Reconciliation of reported and adjusted PBT
$m 	1Q22 	4Q21 	1Q21
Reported PBT 	4,166 	2,664 	5,779
Revenue
Currency translation 	— 	(71) 	(309)
Customer redress programmes 	2 	7 	(18)
Fair value movements on financial instruments 	162 	(16) 	239
Restructuring and other related costs* 	(79) 	112 	66
Currency translation of significant items 	— 	(1) 	(2)
85 	31 	(24)
ECL
Currency translation 	— 	(1) 	(15)
Operating expenses
Currency translation 	— 	47 	213
Customer redress programmes 	4 	25 	(10)
Impairment of goodwill and other intangibles 	— 	587 	—
Restructuring and other related costs 	451 	591 	334
o/w: costs to achieve	
435	
574	
319
Currency translation of significant items 	— 	(2) 	(8)
455 	1,248 	529
Share of profit in associates and joint ventures
Currency translation 	— 	3 	11
— 	3 	11
Total currency translation and significant items 	540 	1,281 	501
Adjusted PBT 	4,706 	3,945 	6,280
Memo: tax on significant items (at reported FX rates) 	(65) 	(101) 	(74)
* Primarily comprises losses associated with RWA reduction commitments

-- 16 of 32 --

16
1Q22 results 	Appendix
Certain items included in adjusted revenue
Certain items included in adjusted revenue highlighted
in management commentary, $m 1Q22 	4Q21 	3Q21 	2Q21 	1Q21
Insurance manufacturing market impacts in WPB 	(275) 	129 	(41) 	331 	67
of which: Asia WPB insurance manufacturing market impacts 	(367)	
88	
(52)	
270	
(81)
Credit and funding valuation adjustments in GBM 	(32) 	43 	(48) 	3 	32
Legacy Credit in Corporate Centre 	(21) 	(14) 	(34) 	6 	9
Valuation differences on long-term debt and associated swaps
in Corporate Centre 5 	(10) 	(35) 	(27) 	(28)
Total 	(323) 	148 	(158) 	313 	80

-- 17 of 32 --

17
1Q22 results 	Appendix
(443)
216
(108)
97
61
177
(51)
(59)
62
89
(112)
(55)
(198)
(403)	(413)
1Q22 adjusted revenue performance
1Q22 revenue 	1Q22 vs. 1Q21 	Revenue by global business, $bn
12.5
5.6
3.2
5.3
1Q21 	4Q21
4.2
3.4
1Q22
0.0
3.5
(0.1)
5.2
3.5
4.0
(0.2)
13.0
12.0
(3)%
Corporate Centre
WPB
CMB
GBM
o/w XVAs: $(64)m
o/w valuation
differences: $33m
(6)%
9%
(4)%	
of which: GLCM
Principal Investments
GLCM
GTRF
Credit and Lending
Other
Wealth
Other
$5,231m
$3,533m
$4,012m
$(227)m
$12,549m 	(3)%
$1,927m
$60m
$521m
$2,371m
$478m
$1,020m
$1,493m
$542m
$124m
MSS
WPB
CMB
GBM
Corp. Centre
Group
Impact of certain items
Banking 	$1,651m
Other 	$(70)m
Personal Banking 	$3,180m
o/w insurance market
impacts: $(342)m

-- 18 of 32 --

18
1Q22 results 	Appendix
Net interest margin supporting information
1Q21 	2Q21 	3Q21 	4Q21 	1Q22 % of 1Q22
Group NII
% of 1Q22
Group AIEA
The Hongkong and
Shanghai Banking
Corporation (HBAP)
1.40% 	1.37% 	1.35% 	1.35% 	1.39% 	47% 	43%
HSBC Bank plc
(NRFB) 0.51% 	0.48% 	0.47% 	0.52% 	0.55% 	9% 	21%
HSBC UK Bank plc
(UK RFB) 1.59% 	1.56% 	1.51% 	1.48% 	1.63% 	25% 	19%
HSBC North America
Holdings, Inc 0.96% 	0.97% 	0.90% 	0.87% 	0.90% 	6% 	8%
Quarterly NIM by key legal entity
Key rates (quarter averages), bps
14 9 	7 	11
20 	19
8 	7 	9 	8 12
33
10 	10 	10 	13
45
75
2Q21	1Q21 	1Q22	3Q21 	2Q22 QTD*	4Q21
1M HIBOR 	Fed effective rate 	BoE Base Rate
Source: Bloomberg 	* At 22 April 2022
Market-implied path of overnight interest rates12, bps
19
224
279
7
272
334
31/12/2022	31/12/2021 	31/12/2023
GBP 	USD
Source: Bloomberg

-- 19 of 32 --

19
1Q22 results 	Appendix
1Q22 financial highlights
Revenue 	$5.2bn (6)%
(1Q21: $5.6bn)
ECL 	$(0.3)bn >(100)%
(1Q21: $0.0bn)
Costs 	$(3.8)bn (2)%
(1Q21: $(3.7)bn)
PBT 	$1.1bn (40)%
(1Q21: $1.9bn)
RoTE 13 	6.9% (11.9)ppts
(1Q21: 18.8%)
Wealth and Personal Banking
(6)%
(1)%
(275)	67 	129	(41)	331
132
2,110
124	232
2,303
3,180	2,964
1Q21
2,993
2Q21
148
3,012
2,208
3Q21
164
3,084
1,890
1Q22	4Q21
2,202
Revenue performance, $m
Wealth excl. market impacts 	Other
Personal banking
Balance sheet, $bn
Reported Wealth Balances14, $bn
4Q21	1Q21 	1Q22
463
824
483
848
488
861
5%
5%
Customer
lending
Customer
accounts
1Q22 vs. 1Q21
 Revenue down $335m (6%). Personal banking up $216m (7%)
from interest rate rises and balance sheet growth. Wealth down
$443m, primarily due to adverse insurance market impacts of
$342m, lower customer activity in equity markets and the impact
of restrictions in Hong Kong, partly offset by higher Insurance
(incl. gain on AXA acquisition of $68m)
 Customer lending up $25bn (5%), mainly mortgages ($24bn,
net of $3bn US balances sold) and unsecured ($1bn)
 Customer accounts up $38bn (5%) across most markets,
particularly in the UK ($20bn) and HK ($14bn), partly offset by
$10bn of reductions related to US sale
 Wealth balances stable, wealth deposits up $19bn (5%) and
NNIA of $41bn over prior 4 quarters offsetting negative equity
market movements on invested assets
1Q22 vs. 4Q21
 Revenue down $36m (1%). Personal banking up $96m (3%)
from higher global interest rates and balance sheet growth.
Wealth down $92m (5%) including adverse insurance market
impacts of $404m, partly offset by private banking and
seasonality
 Customer lending up $5bn (1%), mainly mortgages ($6bn)
across most markets, particularly in the UK ($3bn)
 Customer accounts up $13bn (2%), driven by growth across
most markets, particularly in Hong Kong ($6bn) and the UK ($4bn)
 Wealth balances down $31bn (2%) primarily due to lower
market levels of ($31bn). NNIA of $9bn, mainly in Asia ($8bn)	Insurance manufacturing
market impacts
5,566 	5,566 	5,327 	5,267 	5,231
0%
1Q21
557	538
1,096 	1,082
551
1,119
4Q21 	1Q22
1,633 	1,670 	1,639
(2)%
Invested assets
Wealth deposits

-- 20 of 32 --

20
1Q22 results 	Appendix
1Q22 financial highlights
Revenue 	$3.5bn 9%
(1Q21: $3.2bn)
ECL 	$0.0bn (95)%
(1Q21: $0.2bn)
Costs 	$(1.7)bn (1)%
(1Q21: $(1.7)bn)
PBT 	$1.8bn 3%
(1Q21: $1.8bn)
RoTE 13 	12.1% 0.6ppts
(1Q21: 11.5%)
9%
6%
Commercial Banking
Balance sheet, $bn
4Q21	1Q21 	1Q22
345	336 	355
3%
1Q22	4Q21	1Q21
460 500 	499
(0)%
Customer lending
Customer accounts
Revenue performance, $m
1Q22 vs. 1Q21
 Revenue up $284m (9%) across all regions and core CMB
products, notably in GLCM and GTRF (up over 20% each)
reflecting higher volumes at improved margins with double digit
growth in fees and GBM collaboration income
 Customer lending up $19bn (6%), balances above pre-
pandemic levels with growth notably in Asia, across Trade (up
$12bn, 25%) and C&L (up $5bn)
 Customer accounts up $40bn (9%) with balance growth across
all regions, notably in Asia and the UK
1Q22 vs. 4Q21
 Revenue up $168m (5%) reflecting higher GLCM margins in part
from interest rate rises, continued fee growth notably in Trade
and higher Insurance in Asia reflecting seasonality, GBM
collaboration income (up 16%), partially offset by 4Q C&L one-off
gains
 Customer lending up $9bn (3%) with growth across all regions,
notably C&L (up $6bn) in Asia and North America with continued
momentum in Trade (up $3bn)
 Customer accounts remain stable despite 1Q seasonal
outflows
9%
GLCM
Credit and Lending
GTRF
Markets products, Insurance
and Investments and Other
466	445
3,220
542
3Q21
843
449
1Q21
854
2Q21
447
492
1,492	1,432
3,249
879
369
3,310
509
1,556
931
4Q21
478
529
1,493
1,020
1Q22
1,451
3,365 	3,533
5%

-- 21 of 32 --

21
1Q22 results 	Appendix
1Q22 financial highlights
Revenue 	$4.0bn (4)%
(1Q21: $4.2bn)
ECL 	$(0.3)bn >(100)%
(1Q21: $0.2bn)
Costs 	$(2.5)bn (0)%
(1Q21: $(2.5)bn)
PBT 	$1.2bn (35)%
(1Q21: $1.9bn)
RoTE 13 	8.2% (3.9)ppts
(1Q21: 12.1%)
Global Banking and Markets
View of adjusted revenue
Adjusted RWAs15, $bn
2,430 1,888 	1,951 	1,857 2,371
1,589
1,618 	1,631 	1,648
1,651
(52) 	(10)
2Q21
157
1Q21
(34)
3Q21
(13)
4Q21 	1Q22
4,176
3,472 	3,492	3,530
4,012
(4)% 	15%
Banking	MSS 	Other
Revenue performance, $m
$m 	1Q22 ∆1Q21
MSS 	2,371 	(2)%
Securities Services 	489 	11 %
Global Debt Markets 	208 	(46)%
Global FX 	1,070 	15 %
Equities 	417 	2 %
Securities Financing 	219 	(6)%
XVAs 	(32) 	>(100)%
Banking 	1,651 	4 %
GTRF 	185 	6 %
GLCM 	521 	21 %
Credit & Lending 	607 	(5)%
Capital Markets &
Advisory 290 	2 %
Other 	48 	(23)%
GBM Other 	(10) >(100)%
Principal Investments 	60 	(65)%
Other 	(70) 	>(100)%
Net operating income 	4,012 	(4)%
1Q22 vs. 1Q21
 Revenue down 4% vs. 1Q21:
• 	Global FX and Equities benefitted from strong trading
performance driven by market volatility
• 	Securities Services growth driven by global rate increases,
supported by resilient fee generation
• 	Global Debt Markets adversely impacted by market conditions,
lack of primary activity and subdued client activity
• 	GLCM up reflecting higher global interest rates coupled with
increase in average deposits and fee growth across all regions
• 	Capital Markets and Advisory revenue stable year on year with
the slowdown in Equity Capital Markets and Debt Capital
Markets, offset by continued growth in US Leveraged and
Acquisition Finance
• 	Credit & Lending impacted by strategic actions taken to reduce
RWAs
• 	Principal Investments impacted by lower revaluation gains
 Cumulative RWA savings16 of $83bn achieved since the start of
our transformation programme
1Q22 vs. 4Q21
 Revenue up $520m (15%):
• 	MSS up $514m (28%), reflecting increased activity vs. 4Q21
• 	Banking revenue stable, increases in GLCM were offset by
lower Credit & Lending	1Q22	1Q21 	4Q21
243	250 	234
(3)% 	4%

-- 22 of 32 --

22
1Q22 results 	Appendix
1Q22 financial highlights
Revenue 	$(227)m >(100)%
(1Q21: $(29)m)
ECL 	$(2)m —%
(1Q21: $(2)m)
Costs 	$110m >100%
(1Q21: $(114)m)
Associates 	$648m (27)%
(1Q21: $887m)
PBT 	$529m (29)%
(1Q21: $742m)
RoTE 13 	6.2% (1.2)ppts
(1Q21: 7.4%)
Corporate Centre
Revenue performance, $m
716 	658 549 	578 672
102 14
133
38
1Q21
100
19
2Q21
887
66
3Q21
70
4Q21
(2) (22)
1Q22
779 715 	662 	648
(2)%
Associate income detail, $m
1Q21 	2Q21 	3Q21 	4Q21 	1Q22
Central Treasury 	(28) 	(27) 	(35) 	(10) 	5
Legacy Credit 	9 	6 	(34) 	(14) 	(21)
Other 	(10) 	(57) 	(115) 	(80) 	(211)
Total 	(29) 	(78) 	(184) 	(104) 	(227)
Not included in Corporate Centre revenue: Markets
Treasury revenue allocated to global businesses
783	
500	
514	
490	
503
SABB	BoComm 	Others
1Q22 vs. 4Q21
 Revenue down $123m due to FX losses on hedges
 Associates down $14m (2%), primarily due to a lower share of
profit from associates in the MENA and the UK, partly offset by
Asia
1Q22 vs. 1Q21
 Revenue down $198m, largely due to intersegment eliminations
with GBM and FX losses on hedges
 Associates down $239m (27%), primarily due to the non-
recurrence of 1Q21 revaluation gains in BGF
Adjusted RWAs15, $bn
51	52
40
90
53
4Q21	1Q21
39	37
1Q22
93 	90
(2)% 	(0)%
Associates 	Other

-- 23 of 32 --

23
1Q22 results 	Appendix
1Q22 vs. 4Q21 equity drivers
Shareholders’
Equity, $bn Tangible Equity, $bn TNAV per share, $ Basic number of ordinary
shares, million
As at 31 December 2021 	198.3 	158.2 	7.88 	20,073
Profit attributable to: 	3.3 	2.9 	0.15 	—
Ordinary shareholders 17	
2.8	
2.9	
0.15	
—
Other equity holders	
0.5	
—	
—	
—
Dividends 	(0.5) 	— 	— 	—
On ordinary shares	
—	
—	
—	
—
On other equity instruments	
(0.5)	
—	
—	
—
Cancellation of shares 	— 	— 	— 	(117)
FX 17 	(1.8) 	(1.6) 	(0.08)	
—
Actuarial gains/(losses) on defined benefit plans 	0.7 	0.7 	0.03 	—
Fair value movements through ‘Other Comprehensive Income’ 	(2.2) 	(2.2) 	(0.11) 	—
Of which: changes in fair value arising from changes in own credit risk	
0.9	
0.9	
0.04	
—
Of which: Debt and Equity instruments at fair value through OCI	
(3.0)	
(3.0)	
(0.15)	
—
Other 17 	(1.5) 	(2.2) 	(0.07) 	12
As at 31 March 2022 	196.3 	155.8 	7.80 	19,968
 Average basic number of shares outstanding during 1Q22: 20,024m
 1Q22 TNAV per share decreased by $0.08 to $7.80 per share mainly due to FX and fair value
movements through OCI, partly offset by profits
 1Q22 TNAV excludes the impact of the 2nd interim dividend in respect of FY21 of $0.18 per share, to
be paid at the end of April
$7.74 on a fully diluted
basis
20,134 million on a
fully diluted basis

-- 24 of 32 --

24
1Q22 results 	Appendix
Total shareholders’ equity to CET1 capital
1Q22 	4Q21
Total equity (per balance sheet) 	204,658 	206,777
Non-controlling interests 	(8,365) 	(8,527)
Total shareholders’ equity 	196,293 	198,250
Additional Tier 1 	(22,414) 	(22,414)
Total ordinary shareholders' equity 	173,879 	175,836
Foreseeable dividend 	(5,197) 	(3,655)
Share buyback 	(1,000) 	—
Deconsolidation of insurance/SPE's 	(13,479) 	(13,449)
Allowable NCI in CET1 	4,297 	4,186
CET1 before regulatory adjustments 	158,500 	162,918
Prudential valuation adjustment 	(1,419) 	(1,217)
Intangible assets 	(11,899) 	(9,123)
Deferred tax asset deduction 	(1,579) 	(1,520)
Cash flow hedge adjustment 	1,297 	170
Excess of expected loss 	(2,304) 	(2,020)
Own credit spread and debit valuation adjustment 	671 	1,571
Defined benefit pension fund assets 	(7,797) 	(7,146)
Direct and indirect holdings of CET1 instruments 	(40) 	(40)
Other regulatory adjustments to CET1 capital (including IFRS 9
transitional adjustments when relevant) 223 	766
Threshold deductions 	(14,206) 	(11,794)
Regulatory adjustments 	(37,053) 	(30,353)
CET1 capital 	121,447 	132,565	CET1 capital
Foreseeable dividend
(1,000)
Total equity
Other equity instruments 	(22,414)
(13,479)
Total shareholder’s equity
(5,197)
Non-controlling interests
CET1 before
regulatory adjustments
Regulatory adjustments
173,879
121,447
158,500
Share buyback
196,293
Allowable NCI in CET1
(8,365)
Deconsolidation
of insurance / SPEs
4,297
Total ordinary
shareholder’s equity
(37,053)
204,658
Total equity to CET1 capital, at 31 March 2022, $m 	Total equity to CET1 capital walk, $m

-- 25 of 32 --

25
1Q22 results 	Appendix
Impacts of financial investments
 	As part of our interest rate hedging strategy, we hold a portfolio of financial investments
measured at fair value through other comprehensive income (‘FVOCI’), which are
classified as hold-to-collect-and-sell (‘HTC&S’) 18; the change in value of these
instruments is recognised in equity
 	These instruments are a component of a partial economic hedge of our interest rate
risk position and included in the Group’s disclosed interest rate sensitivity table calculations;
the disclosed interest rate sensitivity shown in the tables is net of these hedging positions
 	The Group remains positively exposed to global interest rate movements (incremental NII
of $5.4bn over 12 months for a parallel shift of +100bps 20)
 	At FY21 we held $349bn of financial investments FVOCI, of which: $247bn debt securities;
$97bn US Treasury bills and similar securities
 	The increase in term market yield curves in 1Q22 drove a pre-tax FVOCI loss of $3.9bn on
HTC&S positions, with a post-tax FVOCI loss of $3.1bn
 	Between 31 March 2022 and 19 April 2022, there has been an additional pre-tax FVOCI
loss of c.$1bn due to the continued steepening of yield curves
 	The increases in yield curves and short rates will benefit Group NII. If policy rates were
to follow market expectations, higher NII is expected to offset FVOCI losses through
increased profitability in 4-6 quarters* (from 31 March 2022)
Debt instruments at FVOCI by product19	Financial investments measured at fair value through OCI
 	Portfolio durations of debt securities measured at
FVOCI typically between 6 months to 10 years;
average duration of 4 years
 	USD securities (incl. US Government agencies and
sponsored entities) are longer duration, and HKD
securities are shorter duration
22%
4%
44%
14%
16%
US sovereign debt
UK sovereign debt
Corporate debt
and other securities
Hong Kong
sovereign debt
Other
government
debt
At 31 December 2021
* Based on a static portfolio composition

-- 26 of 32 --

26
1Q22 results 	Appendix
1Q21 	4Q21 	1Q22
4%
Balance sheet – customer lending
217
463
1
336
483
1,034
205
345
1
488
355
213
0
1,017 1,055
2%
Balances by global business, $bn
Corporate Centre
GBM
CMB
WPB
Adjusted customer lending of
$1,055bn, up $21bn (2%) vs. 4Q21
 WPB lending increased by $5bn (1%),
mainly mortgages (up $6bn), particularly
in the UK
 CMB lending increased by $9bn (3%),
mainly C&L across all regions and
continued growth in trade
 GBM lending up $7bn (4%), primarily
seasonality in GLCM
Balances by region, $bn
Europe
Asia
MENA
North
America
o/w: US
Total
o/w: Hong
Kong
o/w: UK
Latin
America
3
$3bn
3%
1
$7bn
1%
$10bn
3%
$11bn
4%
$1bn
3%
$1bn
3%
$(0)bn
(0)%
$1bn
2%
$21bn
2%
Growth since 4Q21
o/w: mortgages
o/w: mortgages
$396bn
$498bn
$27bn
$113bn
$22bn
$1,055bn
$308bn
$310bn
$54bn

-- 27 of 32 --

27
1Q22 results 	Appendix
6%
460
824
1
327
848
1Q21
861
500
339
1	1
4Q21
499
1Q22
348
1,611 1,689 	1,710
1%
Balance sheet – customer accounts
Balances by global business, $bn
Adjusted customer accounts of
$1,710bn, up $21bn (1%) vs. 4Q21
 WPB customer accounts up $13bn
(2%), driven by growth across most
markets, particularly in Hong Kong ($6bn)
and the UK ($4bn)
 CMB customer accounts stable
despite seasonal outflows
 GBM customer accounts up $9bn
(3%), due to GLCM seasonality
CMB
WPB
GBM
Corporate Centre
Balances by region, $bn
Europe
Asia
MENA
North
America
o/w: US
Total
o/w: Hong
Kong
o/w: UK
Latin
America
$6bn
1%
$1bn
4%
$16bn
3%
$21bn
1%
$15bn
3%
$9bn
2%
$3bn
6%
$(5)bn
(3)%
$(4)bn
(4)%
Growth since 4Q21
$666bn
$795bn
$44bn
$174bn
$31bn
$1,710bn
$535bn
$556bn
$108bn

-- 28 of 32 --

28
1Q22 results 	Appendix
Glossary
AIEA 	Average interest earning assets
AT1 	Additional Tier 1
BGF 	Business Growth Fund, an associate of HSBC
BoCom 	Bank of Communications Co. Limited, an associate of HSBC
Bps 	Basis points. One basis point is equal to one-hundredth of a percentage point
CET1 	Common Equity Tier 1
Corporate Centre Corporate Centre comprises Central Treasury, our legacy businesses, interests in our associates
and joint ventures and central stewardship costs
CMB 	Commercial Banking, a global business
CRE 	Commercial Real Estate
CTA 	Costs to achieve
C&L 	Credit and Lending
ECL
Expected credit losses. In the income statement, ECL is recorded as a change in expected credit
losses and other credit impairment charges. In the balance sheet, ECL is recorded as an
allowance for financial instruments to which only the impairment requirements in IFRS 9 are
applied
GBM 	Global Banking and Markets, a global business
GLCM 	Global Liquidity and Cash Management
GPB 	Global Private Banking
Group 	HSBC Holdings plc and its subsidiary undertakings
GSS 	Green, Social and Sustainability
GTRF 	Global Trade and Receivables Finance
HIBOR 	Hong Kong Interbank Offered Rate
IFRS 	International Financial Reporting Standard
IPO 	Initial Public Offering
LCR 	Liquidity coverage ratio
Legacy credit
A portfolio of assets including securities investment conduits, asset-backed securities, trading
portfolios, credit correlation portfolios and derivative transactions entered into directly with
monoline insurers
MENA 	Middle East and North Africa
MSS 	Markets and Securities Services
NCI 	Non-controlling interests
NII 	Net interest income
NIM 	Net interest margin
NNIA 	Net new invested assets
NRFB 	Non ring-fenced bank in Europe and the UK
OCI 	Other Comprehensive Income
PBT 	Profit before tax
Ppt 	Percentage points
PVIF 	Present value of in-force insurance contracts
SABB 	The Saudi British Bank, an associate of HSBC
UK RFB 	HSBC UK, the UK ring-fenced bank, established July 2018 as part of ring fenced bank legislation
RoTE 	Return on average tangible equity
RWA 	Risk-weighted asset
TNAV 	Tangible net asset value
T&E 	Travel and entertainment
VNB 	Value of new business written
WPB 	Wealth and Personal Banking, a global business
XVAs 	Credit and Funding Valuation Adjustments

-- 29 of 32 --

29
1Q22 results 	Appendix
Footnotes
1. 	Unless otherwise stated, regulatory capital ratios and requirements are based on the transitional arrangements of the Capital Requirements Regulation in force at the time. These include the
regulatory transitional arrangements for IFRS 9 ‘Financial Instruments’. The leverage ratio is calculated using the end point definition of capital and the IFRS 9 regulatory transitional
arrangements, in line with the UK leverage rules that were implemented on 1 January 2022, and excludes central bank claims. Comparatives for 2021 are reported based on the disclosure
rules in force at that time, and include claims on central banks. References to EU regulations and directives (including technical standards) should, as applicable, be read as references to
the UK’s version of such regulation and/or directive, as onshored into UK law under the European Union (Withdrawal) Act 2018, and subsequently amended under UK law
2. 	Source: Dealogic from 1 January 2022 - 21 April 2022. Ranking based on apportioned deal amount by bookrunner
3. 	For further information please see our press release titled: “HSBC announces net zero steps” on hsbc.com
4. 	Source: Dealogic at 31 March 2022, data as at 22 April 2022. Global GSS bonds
5. 	Percentage is calculated excluding self-service machine transactions (excludes HASE and GPB)
6. 	Reported RoTE is computed by adjusting annualised reported results for PVIF and for impairment of goodwill and other intangible assets (net of tax), divided by average reported equity
adjusted for goodwill, intangibles and PVIF for the period
7. 	Based on current consensus economic forecasts and default experience
8. 	Technology costs in operating expenses trends include transformation saves and are presented on a net basis
9. 	Technology cost increases in quarterly walks are presented on a gross basis (excl. saves)
10. Regulatory dividend accrual for the purposes of capital calculations. Over 1Q22 we accrued 7.6¢, equal to 55% of reported EPS of 14¢. In line with our dividend policy, we will retain the
flexibility to adjust EPS for non-cash significant items. Additionally, in 2022, we expect to exclude from EPS the forecast loss on the sale of our retail banking operations in France
11. If policy rates were to follow the current implied market consensus
12. Source: Bloomberg. GBP: Sterling Overnight Index Average (SONIA); USD: Fed funds. Implied rates for 31 December 2022 and 2023 based on the following as of 22 April 2022: 30 day Fed
Funds futures and one month SONIA index future
13. YTD, annualised. RoTE by Global Business excludes significant items. RoTE methodology annualises Profits Attributable to Shareholders, including ECL, in order to provide a returns metric.
RoTE by Global Business considers AT1 Coupons on an accruals basis, vs. Reported RoTE where it is treated on a cash basis
14. Wealth deposits include Premier, Jade and Global Private Banking deposits, which include Prestige deposits in Hang Seng Bank, and form part of the total WPB customer accounts balance
15. Data to reconcile components of reported RWAs to adjusted RWAs can be found in the ‘HSBC Holdings plc 1Q 2022 Datapack’
16. Cumulative RWA saves under our transformation programs as measured from 1 January 2020, including $9.6bn of accelerated saves made over 4Q19
17. Differences between shareholders’ equity and tangible equity drivers primarily reflect AT1 capital, goodwill and other intangibles and PVIF. ‘Profit Attributable to Ordinary shareholders’
differences primarily include goodwill and other intangibles impairment, PVIF movements and amortisation expense. ‘FX’ differences primarily include FX on goodwill and intangibles.
‘Other’ differences primarily include intangible additions and redemption of securities
18. HTC&S portfolio stressed value at risk (VaR) of $3.6bn at FY21. HTC&S portfolio stressed VaR assumes a holding period of 60 days; details on sensitivity of capital and reserves can be found
on p.201 of the 2021 HSBC Holdings plc Annual Report and Accounts; additional quantitative information on interest rate risk in the banking book, including changes in the economic value
of equity in relation to changes in yield curves can be found on p.75 of the HSBC Holdings plc Pillar 3 Disclosures at 31 December 2021
19. Product allocations are made on an amortised cost basis
20. Interest rate sensitivity disclosures can be found on p.200 of the HSBC Holdings plc Annual report and Accounts 2021

-- 30 of 32 --

30
1Q22 results 	Appendix
Disclaimer
Important notice
The information, statements and opinions set out in this presentation and accompanying discussion (“this Presentation”) are for informational and reference purposes only and do not constitute a public offer for the purposes of any applicable law or
an offer to sell or solicitation of any offer to purchase any securities or other financial instruments or any advice or recommendation in respect of such securities or other financial instruments.
This Presentation, which does not purport to be comprehensive nor render any form of legal, tax, investment, accounting, financial or other advice, has been provided by HSBC Holdings plc (together with its consolidated subsidiaries, the “Group”)
and has not been independently verified by any person. You should consult your own advisers as to legal, tax investment, accounting, financial or other related matters concerning any investment in any securities. No responsibility, liability or
obligation (whether in tort, contract or otherwise) is accepted by the Group or any member of the Group or any of their affiliates or any of its or their officers, employees, agents or advisers (each an “Identified Person”) as to or in relation to this
Presentation (including the accuracy, completeness or sufficiency thereof) or any other written or oral information made available or any errors contained therein or omissions therefrom, and any such liability is expressly disclaimed.
No representations or warranties, express or implied, are given by any Identified Person as to, and no reliance should be placed on, the accuracy or completeness of any information contained in this Presentation, any other written or oral information
provided in connection therewith or any data which such information generates. No Identified Person undertakes, or is under any obligation, to provide the recipient with access to any additional information, to update, revise or supplement this
Presentation or any additional information or to remedy any inaccuracies in or omissions from this Presentation. Past performance is not necessarily indicative of future results. Differences between past performance and actual results may be
material and adverse.
Forward-looking statements
This Presentation may contain projections, estimates, forecasts, targets, opinions, prospects, results, returns and forward-looking statements with respect to the financial condition, results of operations, capital position, strategy and business of the
Group which can be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “plan”, “estimate”, “seek”, “intend”, “target”, “believe”, "potential" and "reasonably possible" or the
negatives thereof or other variations thereon or comparable terminology (together, “forward-looking statements”), including the strategic priorities and any financial, investment and capital targets and any ESG related targets, commitments and
ambitions described herein. Any such forward-looking statements are not a reliable indicator of future performance, as they may involve significant stated or implied assumptions and subjective judgements which may or may not prove to be correct.
There can be no assurance that any of the matters set out in forward-looking statements are attainable, will actually occur or will be realised or are complete or accurate. The assumptions and judgments may prove to be incorrect and involve known
and unknown risks, uncertainties, contingencies and other important factors, many of which are outside the control of the Group. Actual achievements, results, performance or other future events or conditions may differ materially from those stated,
implied and/or reflected in any forward-looking statements due to a variety of risks, uncertainties and other factors (including without limitation those which are referable to general market conditions, regulatory changes, geopolitical tensions such as
the Russia-Ukraine war, the impact of the Covid-19 pandemic or as a result of data limitations and changes in applicable methodologies in relation to ESG related matters). Any such forward-looking statements are based on the beliefs, expectations
and opinions of the Group at the date the statements are made, and the Group does not assume, and hereby disclaims, any obligation or duty to update, revise or supplement them if circumstances or management’s beliefs, expectations or opinions
should change. For these reasons, recipients should not place reliance on, and are cautioned about relying on, any forward-looking statements. No representations or warranties, expressed or implied, are given by or on behalf of the Group as to the
achievement or reasonableness of any projections, estimates, forecasts, targets, commitments, prospects or returns contained herein.
Additional detailed information concerning important factors that could cause actual results to differ materially from this Presentation is available in our Annual Report and Accounts for the fiscal year ended 31 December 2021 filed with the Securities
and Exchange Commission (the “SEC”) on Form 20-F on 23 February 2022 (the “2021 Form 20-F”) and our 1Q 2022 Earning Release which we expect to furnish with the SEC on Form 6-K on 26 April 2022 (the “Q1 2022 Earnings Release”).
Alternative Performance Measures
This Presentation contains non-IFRS measures used by management internally that constitute alternative performance measures under European Securities and Markets Authority guidance and non-GAAP financial measures defined in and presented
in accordance with SEC rules and regulations (“Alternative Performance Measures”). The primary Alternative Performance Measures we use are presented on an “adjusted performance” basis which is computed by adjusting reported results for the
period-on-period effects of foreign currency translation differences and significant items which distort period-on-period comparisons. Significant items are those items which management and investors would ordinarily identify and consider
separately when assessing performance in order to better understand the underlying trends in the business.
Reconciliations between Alternative Performance Measures and the most directly comparable measures under IFRS are provided in our 2021 Form 20-F and our Q1 2022 Earnings Release, when filed, each of which are available at www.hsbc.com.
Information in this Presentation was prepared as at 26 April 2022.

-- 31 of 32 --



-- 32 of 32 --